Back
Results - Announcements
Sales rise 35.81% to Rs 526.31 crore
Astrazeneca Pharma India reports standalone net profit of Rs 55.83 crore in the June 2025 quarter
14-Aug-2025, 03:12
Net profit of Astrazeneca Pharma India reported to Rs 55.83 crore in the quarter ended June 2025 as against net loss of Rs 11.79 crore during the previous quarter ended June 2024. Sales rose 35.81% to Rs 526.31 crore in the quarter ended June 2025 as against Rs 387.52 crore during the previous quarter ended June 2024.
Net profit of Astrazeneca Pharma India reported to Rs 55.83 crore in the quarter ended June 2025 as against net loss of Rs 11.79 crore during the previous quarter ended June 2024. Sales rose 35.81% to Rs 526.31 crore in the quarter ended June 2025 as against Rs 387.52 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 526.31 | 387.52 | 36 |
| OPM % | 15.41 | 9.82 | - |
| PBDT | 91.63 | 46.31 | 98 |
| PBT | 75.06 | 42.40 | 77 |
| NP | 55.83 | -11.79 | LP |
Powered by Capital Market - Live News